TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Roche Diagnostics Norge AS
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
2,255,325
|
1,372,515
|
643,118 |
| Financial expenses |
1,315
|
701
|
1,075 |
| Earnings before taxes |
105,129
|
21,293
|
25,027 |
| Total assets |
362,681
|
653,557
|
343,077 |
| Current assets |
315,578
|
639,125
|
324,034 |
| Current liabilities |
268,450
|
540,832
|
246,517 |
| Equity capital |
94,230
|
112,725
|
96,560 |
| - share capital |
5,840
|
5,840
|
5,840 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
26.0%
|
17.2%
|
28.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.7%
|
1.6%
|
3.9% |
| Return on assets (ROA) |
29.3%
|
3.4%
|
7.6% |
| Current ratio |
117.6%
|
118.2%
|
131.4% |
| Return on equity (ROE) |
111.6%
|
18.9%
|
25.9% |
| Change turnover |
882,810
|
729,397
|
105,701 |
| Change turnover % |
64%
|
113%
|
20% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.